- Home
- POCI vs ANTX Comparison
POCI vs ANTX Comparison
Compare POCI & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- ANTX
- Stock Information
- Founded
- POCI 1982
- ANTX 2017
- Country
- POCI United States
- ANTX United States
- Employees
- POCI N/A
- ANTX N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- POCI Health Care
- ANTX Health Care
- Exchange
- POCI Nasdaq
- ANTX Nasdaq
- Market Cap
- POCI 32.4M
- ANTX 37.3M
- IPO Year
- POCI N/A
- ANTX 2022
- Fundamental
- Price
- POCI $4.32
- ANTX $1.06
- Analyst Decision
- POCI
- ANTX Buy
- Analyst Count
- POCI 0
- ANTX 3
- Target Price
- POCI N/A
- ANTX $2.00
- AVG Volume (30 Days)
- POCI 32.7K
- ANTX 319.1K
- Earning Date
- POCI 05-15-2025
- ANTX 05-13-2025
- Dividend Yield
- POCI N/A
- ANTX N/A
- EPS Growth
- POCI N/A
- ANTX N/A
- EPS
- POCI N/A
- ANTX N/A
- Revenue
- POCI $17,626,155.00
- ANTX N/A
- Revenue This Year
- POCI N/A
- ANTX N/A
- Revenue Next Year
- POCI N/A
- ANTX N/A
- P/E Ratio
- POCI N/A
- ANTX N/A
- Revenue Growth
- POCI N/A
- ANTX N/A
- 52 Week Low
- POCI $3.47
- ANTX $0.87
- 52 Week High
- POCI $6.90
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- POCI 47.11
- ANTX 34.59
- Support Level
- POCI $4.10
- ANTX $1.11
- Resistance Level
- POCI $4.68
- ANTX $1.22
- Average True Range (ATR)
- POCI 0.33
- ANTX 0.06
- MACD
- POCI -0.02
- ANTX -0.00
- Stochastic Oscillator
- POCI 28.30
- ANTX 21.74
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.